Clinical Trials Logo

Clinical Trial Summary

The main purpose of this study is to compare two types of treatment of hydrocephalus: placement of a ventriculoperitoneal (VP) shunt versus an endoscopic third ventriculostomy (ETV). A second goal of this study will be to understand how the two different types of procedures, VP shunt versus ETV, affect brain blood flow and pressures. Understanding these changes is important because the investigators hope is to someday be able to predict who will better respond to one procedure or another.


Clinical Trial Description

The management of normal pressure hydrocephalus (NPH) is challenging due to diagnostic uncertainties and high treatment risks. To date, there are no evidence-based treatment standards for this disorder. Our long-term goal is to improve the outcome of NPH improving our understanding of cerebrospinal fluid (CSF) hydrodynamics. The Specific Aims are to 1) determine the value of a high volume tap test, and 2) determine whether intracranial hemo/hydrodynamic variables, measured before a shunt operation, support the tuned-dynamic absorber model of intracranial pressure dynamics.

The study's Aim relates to modeling the complex hydro- and hemodynamics of intracranial physiology-pathology. We hypothesize that current hydrocephalus models are over-simplistic and that shunt-induced hydrodynamics are better modeled based on ICP waveform characteristics and the application of novel dynamic models. Much of the data for this Aim will be passively recorded during the routine care of the patient. In essence, we are only adding noninvasive MRI studies and TCD (transcranial Doppler) studies.

The experimental methodology is aimed at altering the intracranial compartment compliance by placing the patient in various positions so that these phase differences can be detected. The simplest way to alter intracranial compliance is to make postural changes. When a patient is in the Trendelenburg position, venous outflow out of the brain is hindered resulting in an increase in ICP and presumably a reduction in compliance. Conversely, raising the head of bed to 60 degrees will result in the opposite effect. The second mechanism of altering compliance (and ICP) will occur as a result of treating the hydrocephalus with a CSF shunt. Because we are able to study hydrocephalus patients prior to shunting as part of their diagnostic workup, we create a new state with the shunt that will allow us to further characterize the intracranial system. ;


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01115270
Study type Observational
Source University of California, Los Angeles
Contact
Status Completed
Phase N/A
Start date February 2007
Completion date October 2011

See also
  Status Clinical Trial Phase
Completed NCT04599153 - MRI-Volumetry in the Evaluation of Shunt Treatment for Hydrocephalus N/A
Recruiting NCT06083233 - Role of Brain Specific Biomarkers in Hydrocephalus N/A
Active, not recruiting NCT04785560 - Volumetrics and Proteomics in Shunted Normal Pressure Hydrocephalus N/A
Recruiting NCT05250505 - Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus N/A
Terminated NCT03076723 - Using Cerebrospinal Fluid Dynamics to Optimize Treatment of Idiopathic Normal Pressure Hydrocephalus N/A
Recruiting NCT04011566 - Assessment of ShuntCheck Performance Characteristics in Asymptomatic Patients With Normal Pressure Hydrocephalus
Recruiting NCT04309487 - Diagnostic Accuracy of ShuntCheck Compared to Radionuclide Shunt: Patency in Patients With Normal Pressure Hydrocephalus
Completed NCT02659111 - Effects of Physical Training in iNPH N/A
Completed NCT01850914 - Vascular Risk Factors in INPH-patients N/A
Completed NCT05204745 - Ventriculomegaly and Gait Disturbance in the Senior Population in the Region of Västerbotten
Recruiting NCT05232838 - US Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus N/A